Ornovi is apreclinical stage therapeutics company developing treatments for inflammatory and autoimmune diseases. Its key asset is a selective JAK3/ITK dual inhibitor for the treatment of alopecia areata, vitiligo, and other inflammatory and autoimmune diseases where JAK3 plays a role.

‍